These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32887736)

  • 1. Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome.
    Peck KY; Andrianopoulos N; Dinh D; Roberts L; Duffy SJ; Sebastian M; Clark D; Brennan A; Oqueli E; Ajani AE; Reid CM; Freeman M; Teh AW
    Heart; 2021 May; 107(9):728-733. PubMed ID: 32887736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.
    Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction ≥ 40.
    Abi Khalil C; Sulaiman K; Asaad N; AlHabib KF; Alsheikh-Ali A; Jameesh M; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Panduranga P; Mahfoud Z; Al Suwaidi J
    Curr Vasc Pharmacol; 2020; 18(6):644-651. PubMed ID: 31889498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of
    Chen Y; Tang XF; Gao RL; Yang YJ; Xu B; Yuan JQ
    Cardiovasc Ther; 2020; 2020():4351469. PubMed ID: 32405323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).
    Abi Khalil C; AlHabib KF; Singh R; Asaad N; Alfaleh H; Alsheikh-Ali AA; Sulaiman K; Alshamiri M; Alshaer F; AlMahmeed W; Al Suwaidi J
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29263035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention.
    Kırıs T; Avcı E; Çelik A
    BMC Cardiovasc Disord; 2018 Mar; 18(1):44. PubMed ID: 29499644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis.
    Maqsood MH; Alam M; Atar D; Birnbaum Y
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):87-93. PubMed ID: 33136764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
    Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
    EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.
    Peyracchia M; Errigo D; Raposeiras Rubin S; Conrotto F; DiNicolantonio JJ; Omedè P; Rettegno S; Iannaccone M; Moretti C; D'Amico M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):337-343. PubMed ID: 29877974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention.
    Choo EH; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Heart; 2014 Mar; 100(6):492-9. PubMed ID: 24395980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry.
    D'Ascenzo F; Celentani D; Brustio A; Grosso A; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Kedev S; Moretti C; D'Amico M; Gaita F
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):299-309. PubMed ID: 29691803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial Strain for Identification of β-Blocker Responders in Heart Failure with Preserved Ejection Fraction.
    Park JJ; Choi HM; Hwang IC; Park JB; Park JH; Cho GY
    J Am Soc Echocardiogr; 2019 Nov; 32(11):1462-1469.e8. PubMed ID: 31540679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors profile in patients with acute coronary syndrome with particular reference to left ventricular ejection fraction.
    Khaled S; Matahen R
    Indian Heart J; 2018; 70(1):45-49. PubMed ID: 29455787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].
    Jiang L; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Gao LJ; Song L; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1058-1066. PubMed ID: 29325366
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of left ventricular function on clinical outcomes among patients with coronary artery disease.
    Siontis GC; Branca M; Serruys P; Silber S; Räber L; Pilgrim T; Valgimigli M; Heg D; Windecker S; Hunziker L
    Eur J Prev Cardiol; 2019 Aug; 26(12):1273-1284. PubMed ID: 30966820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of acute myocardial infarction patients with mid-range ejection fraction after emergency percutaneous coronary intervention.
    Jiang Y; Hu S; Cao M; Li X; Zhou J; Ding B; Zhang F; Chen T; Zhou Y
    Postgrad Med J; 2019 Jul; 95(1125):355-360. PubMed ID: 31129629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of mid-range ejection fraction following acute coronary syndrome (ANZACS-QI 23).
    Chan D; Doughty RN; Lund M; Lee M; Poppe K; Kerr AJ
    N Z Med J; 2021 Jan; 134(1528):57-78. PubMed ID: 33444307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.